查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702123

2025 年至 2033 年兒科疫苗市場報告，按類型（多價、單價）、技術（結合疫苗、減毒活疫苗、去活化疫苗、次單位疫苗、類毒素疫苗及其他）、應用（傳染病、癌症、過敏症及其他）和地區分類

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024年全球兒科疫苗市場規模達397億美元。展望未來， IMARC Group預計到2033年市場規模將達到727億美元，2025-2033年期間的成長率（CAGR）為6.89%。疫苗接種計劃的不斷實施、對聯合疫苗的日益關注以及製藥公司和醫療保健組織之間為加快疫苗的開發和分發而不斷加強的合作是推動市場發展的一些主要因素。

兒童疫苗是一種刺激免疫系統辨識和對抗特定傳染源（如細菌或病毒）的藥物製劑。它們由病原體的弱化或去活化形式或病原體的成分組成，促使免疫系統針對目標疾病產生防禦機制。它們可以預防麻疹、小兒麻痺、百日咳、肝炎和流感。在批准使用之前，它們要經過嚴格的測試和評估，以確保其安全性。它們可以防止可能導致兒童嚴重併發症或死亡的疾病傳播。

目前，兒童中各種傳染性和潛在危及生命的疾病（如小兒麻痺、結核病和瘧疾）的發病率不斷上升，推動市場的成長。除此之外，世界各國政府也越來越採取舉措，為兒童接種可預防疾病的疫苗，也促進了市場的成長。此外，疫苗儲存和分發方法的技術不斷進步，改善了醫療基礎設施低度開發地區的供應鏈，為市場前景提供了良好的前景。除此之外，製藥公司和醫療保健組織之間日益加強的合作，加速了疫苗的研發和分發，也支持了市場的成長。此外，世界各地為改善醫療服務而不斷增建的診所和醫院也促進了市場的成長。

兒科疫苗市場趨勢/促進因素：

疫苗接種計劃的開展日益加強

疫苗接種計劃的持續實施顯著促進了兒科疫苗市場的發展。這些疫苗接種措施得到了政府和非政府組織的支持，在保障兒童的健康和福祉方面發揮關鍵作用。隨著越來越多的兒童接受各種疾病的必要免疫接種，兒童疫苗的需求也隨之增加。此外，以預防疾病為重點的疫苗接種計劃正在降低兒童目標疾病的發生率。這進而減輕了醫療保健系統和家庭的負擔，從而提高了兒童及其照顧者的整體生活品質。此外，家長和醫療保健提供者對免疫接種重要性的認知不斷提高，疫苗接種率也在上升。

越來越關注聯合疫苗

對聯合疫苗的高度重視促進了兒科疫苗市場的積極發展。聯合疫苗透過單一配方提供對多種疾病的保護，為免疫接種提供了一種策略方法。這種方法簡化了醫療保健提供者、護理人員和兒童的疫苗接種過程，從而提高了依從性和疫苗覆蓋率。此外，聯合疫苗解決了疫苗猶豫和漏接種的可能性的問題。由於兒童只需注射一次疫苗即可預防多種疾病，因此疫苗接種的負擔顯著減輕。這鼓勵父母遵守建議的疫苗接種時間表，並有助於實現更高的全面免疫覆蓋率。

新型疫苗研發不斷湧現

新型疫苗的持續發展在推動兒科疫苗市場積極成長方面發揮關鍵作用。專門針對兒童健康需求的新型疫苗的出現有助於加強疾病預防、改善公共衛生結果並擴大市場機會。新型疫苗的開發也反映了疫苗技術和研究的進步。基因組學和生物資訊學等尖端研究方法使科學家能夠更快、更準確地識別潛在的疫苗候選物。這種加速的發現步伐正在創造出有效且符合不斷變化的流行病學情況的疫苗。此外，新型疫苗的持續發展正在刺激公共衛生組織、研究機構和疫苗製造商之間的合作。這些合作關係有助於及時推出新疫苗，並確保其有效分發給兒科族群。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球兒科疫苗市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 多價
  • 單價

第7章：市場區隔：依技術

  • 共軛
  • 減毒活疫苗
  • 去活化
  • 亞基
  • 類毒素
  • 其他

第 8 章：市場區隔：按應用

  • 傳染病
  • 癌症
  • 過敏
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Bio-Med Private Limited
    • Daiichi Sankyo Company Limited
    • GSK plc
    • Indian Immunologicals Limited (National Dairy Development Board)
    • Merck & Co. Inc.
    • Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Sanofi SA
    • Sinovac Biotech Ltd.
Product Code: SR112025A6230

The global pediatric vaccines market size reached USD 39.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 72.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.89% during 2025-2033. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

Pediatric Vaccines Market Trends/Drivers:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

Pediatric Vaccines Industry Segmentation:

Breakup by Type:

  • Multivalent
  • Monovalent

Multivalent dominates the market

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

  • Conjugate
  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Others

Conjugate holds the largest share in the market

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

  • Infectious Disease
  • Cancer
  • Allergy
  • Others

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

Competitive Landscape:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Bio-Med Private Limited
  • Daiichi Sankyo Company Limited
  • GSK plc
  • Indian Immunologicals Limited (National Dairy Development Board)
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sanofi S.A.
  • Sinovac Biotech Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global pediatric vaccines market in 2024?
  • 2.What is the expected growth rate of the global pediatric vaccines market during 2025-2033?
  • 3.What are the key factors driving the global pediatric vaccines market?
  • 4.What has been the impact of COVID-19 on the global pediatric vaccines market?
  • 5.What is the breakup of the global pediatric vaccines market based on the type?
  • 6.What is the breakup of the global pediatric vaccines market based on the technology?
  • 7.What are the key regions in the global pediatric vaccines market?
  • 8.Who are the key players/companies in the global pediatric vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Med Private Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 GSK plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Panacea Biotec Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinovac Biotech Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players